Keywords: Novartis, Sandoz, Alcon, First-quarter financial results

Novartis 1st-qtr 2011 hit by strong franc but still beats forecasts

Article | 19 April 2011

Swiss drug major Novartis (NOVN: VX) reported a 16% rise (+14% at constant currencies) in first-quarter 2011 sales to $14.0 billion, ahead of consensus ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Alcon

Sandoz

Go to company listing